Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Some Like it Hot: Campbell Soup Company (CPB)

Page 1 of 2

Berkshire Hathaway Inc. (NYSE:BRK.B)’s recent $28 billion purchase of H.J. Heinz for $72.50 a share, a healthy 20% premium to Heinz’s all-time high, thrust a bevy of other food companies into the spotlight, including Campbell Soup Company (NYSE:CPB).

Shares of the Camden, N.J. based company, behind such iconic brands as Campbell’s Soup, Pepperidge Farms and V8 juices, were juiced almost 6% following the Heinz deal. Also giving shares a hearty boost was a research report from Goldman Sachs. The investment powerhouse reaffirmed its “Buy” rating on shares of Campbell with a $40 price target.

Campbell Soup Company (NYSE:CPB)“We recommend investors buy CPB ahead of what we believe could be a topline driven 2Q13 beat on the back of better-than-expected soup volumes and strength in its global baking business. Our sales and EPS (earnings per share) for the quarter are 3% and 5% above consensus, respectively. The stock continues to trade at a 20% P/E multiple discount to the overall food group,” Goldman wrote in their fresh report.

Since Denise Morrison took over in 2010 as CEO of the world’s largest soup maker, she has led the company in recognizing consumers’ steady shift toward healthy products, fresh food and easy-to-prepare items. The move steered the company to engage in its largest acquisition in its storied 140 year history when it bought Bakersfield, CA based natural food and beverage distributor Bolthouse Farms in July 2012. The acquisition added 10% to Campbell’s bottom line in the latest quarter.

Campbell’s new health conscious culture and always on-the-move consumer focus is also responsible for its new lines of skillet-friendly sauces and soups-to-go packaged in pouches instead of the company’s legendary cans. Both have been well received.

Sales of its Chunky soups rose double digits in its fiscal second quarter thanks to a redesigned label and advertising ties to the National Football League. The company also reported higher-than-expected profit in the quarter.

Campbell’s inspiring quarter was a bright spot in a sector that has been showing lackluster earnings. Kraft Foods Group Inc (NASDAQ:KRFT) has experienced a slide as it continues to adjust to the recent spinoff from Mondelez International Inc (NASDAQ:MDLZ).

Kraft’s organic revenue—a measure that reflects the company’s comparable sales excluding foreign exchange transactions—slipped 7.2% in the latest quarter, a drop deeper than expected. The slide was attributed to retailers’ working through excess inventory they accumulated prior to Kraft’s October 2012 shedding of Mondelez, which prevented retailers from placing new orders.

Also weighing on Kraft during the quarter was a push by retailers promoting low-priced offerings, an area where Kraft’s products didn’t mesh with the tactic.

Meanwhile Mondelez, the maker of Oreo cookies, Tang, Cadbury and a host of other snacks, missed on both top and bottom lines in the latest quarter. Earnings per shares tumbled to 30 cents a share from 47 cents in the same quarter a year ago. Revenue was trimmed 2% year-over-year to $9.5 billion.

The snack food company has a large global presence and was adversely affected as overseas currencies got clipped and the U.S. dollar gained ground.

On the menu of food companies that look appetizing, Campbell is the cheapest with a P/E of 15.2. In comparison, Kraft’s P/E is 17.8, Mondelez’s is 16, Hormel Foods Corporation (NYSE:HRL) trades with of P/E of 18.4 and The Hershey Company (NYSE:HSY)’s P/E is 22.2.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!